What is Bicara Therapeutics's net investment in lease?

Bicara Therapeutics (BCAX) reported net investment in lease of $1.43M in Q1 2026.

How has Bicara Therapeutics's net investment in lease changed year-over-year?

Bicara Therapeutics's net investment in lease increased by 158.7% year-over-year, from $552K to $1.43M.

What is the long-term trend for Bicara Therapeutics's net investment in lease?

Over 2 years (2023 to 2025), Bicara Therapeutics's net investment in lease has grown at a 66.6% compound annual growth rate (CAGR), from $613K to $1.7M.

Bicara Therapeutics BCAX Net Investment in Lease

Net Investment in Lease at other companies

ArriVent BioPharma, Inc.AVBP

——

Inhibrx Biosciences, Inc.INBX

——

ImmunomeIMNM

——

Syndax PharmaceuticalsSNDX

——

Nuvation BioNUVB

——

Viridian Therapeutics, Inc.VRDN

——

Other financials

Income statement

See full

Operating income-$60.2M-44.2%

Net income-$56.2M-52.6%

EPS (diluted)-$0.93-36.8%

Balance sheet

See full

Cash & equivalents$323.5M-30.0%

Total debt$1.4M+144%

Total equity$514.0M+12.0%

Total assets$553.6M+15.8%

Cash flow

See full

Operating cash flow-$37.5M-33.5%

CapEx$60.0K—

Free cash flow-$37.6M-33.7%

Valuation

See full

Market cap$1.68B+81.4%

Returns & leverage

See full

Return on equity-32.3%—

Debt / equity0×0.0×

Current ratio13.9×-10.8×

Where this comes from

Reported directly by Bicara Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Bicara Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bicara Therapeutics's net investment in lease.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Bicara Therapeutics's net investment in lease?: Bicara Therapeutics (BCAX) reported net investment in lease of $1.43M in Q1 2026.
How has Bicara Therapeutics's net investment in lease changed year-over-year?: Bicara Therapeutics's net investment in lease increased by 158.7% year-over-year, from $552K to $1.43M.
What is the long-term trend for Bicara Therapeutics's net investment in lease?: Over 2 years (2023 to 2025), Bicara Therapeutics's net investment in lease has grown at a 66.6% compound annual growth rate (CAGR), from $613K to $1.7M.